Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia

Diabetes Care

Volumn 19, Issue 11, 1996, Pages 1207-1213

  Rivellese, Angela A ^a   Maffettone, Ada ^b   Iovine, Ciro ^b   Di Marino, Lucrezia ^b   Annuzzi, Giovanni ^b   Mancini, Mario ^b   Riccardi, Gabriele ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; GLUCOSE; ICOSAPENTAENOIC ACID; INSULIN; LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0029964924     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.11.1207     Document Type: Article

References (46)

1. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
2. De Fronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
3. Yki-Jarvinen H, Taskinen MR: Interrelationship among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia. Diabetes 37:1271-1278, 1988
4. Laakso M, Sarlund H, Mykkanen L: Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10:223-231, 1990
5. Laakso M, Uusitupa M, Takala J, Majander M, Reijonent I, Penttila I: Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hypoglycemia in obese non insulin-dependent diabetic subjects. Metabolism 37: 1092-1100, 1988
6. Vessby B: Nutrition, lipids and diabetes mellitus. Curr Op Lipid 6:3-7, 1995
7. Riccardi G, Rivellese AA: Effects of dietary fiber and carbohydrate on glucose and lipoprotein metabolism in diabetic patients. Diabetes Care 14:1115-1125, 1991
8. Parillo M, Rivellese AA, Ciardullo AV, Capaldo B, Giacco A, Genovese S, Riccardi G: A high monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism 12:1373-1378, 1992
9. Storlien LH, Kraegen EW, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW: Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237:885-888, 1987
10. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW: Influence of dietary fat composition on development of insulin resistance in rats. Diabetes 40:280-289, 1991
11. Yorek M, Leeney E, Dunlap J, Ginsberg B: Effect of fatty acid composition on insulin and IGF-1 binding in retinoblastoma cells. Invest Ophthalmol Vis Sci 30:2087-2092, 1989
12. Field CJ, Ryan EA, Thomson ABR, Clanidin MT: Dietary fat and the diabetic state alter insulin binding and the fatty acyl composition of the adipocyte plasma membrane. Biochem J 253:417-424, 1988
13. Hagve TA: Effects of unsaturated fatty acids on cell membrane functions. Scand J Lab Invest 48:381-388, 1988
14. Annuzzi G, Rivellese A, Capaldo B, Di Marino L, Iovine C, Marotta G, Riccardi G: A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients. Atherosclerosis 87:65-73, 1991
15. Borkman M, Chisholm DJ, Furler SM, Storlien LH, Kraegen EW, Simons LA, Chesterman CN: Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 38:1314-1319, 1989
16. Popp Snijders C, Schouten JA, Heine RJ, Van der Meer J, Van der Veen EA: Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non insulin dependent diabetes. Diabetes Res 14:141-147, 1987
17. Feskens EJM, Bowles CH, Kromhout D: Inverse association between fish intake and risk of glucose intolerance in normoglycaemic elderly men and women. Diabetes Care 14:934-941, 1991
18. Mouratoff GJ, Carroll NV, Scott EM: Diabetes mellitus in Eskimos. JAMA 199:107-112, 1966
19. Lands WEM: n-3 fatty acids as precursors for active metabolic substances: dissonance between expected and observed events. J Int Med 225 (Suppl. 1): 11-20, 1989
20. WHO Expert Committee on Diabetes Mellitus: Second report. Geneva, World Health Organization, 1980, p. 7-14 (Tech. Rep. Ser., No. 646)
21. Beamont JL, Carlsson LA, Cooper GR, Fejfar Z, Frederickson DS, Strasser T: Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull WHO 43:891-908, 1970
22. De Fronzo RA, Totin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
23. 1c. Diabetes 27:102-107, 1978
24. Debuquois B, Aurbach GD: Use of polyethylene glycol to separate free and antibody bound peptide hormones in radioimmunoassay. J Clin Endocrinol Metab 33:732-738, 1971
25. Noma A, Okabe Ft, Kita M: A new colonmetric microdetermination of free fatty acids in serum. Clin Chim Acta 43:317-323, 1973
26. Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW: Improved reagent for enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem 19:838-839, 1981
27. Wahlefeld AW: Triglycerides determination after enzymatic hydrolysis. In Methods of Enzymatic Analysis. Vol. 4, 2nd ed. Bergmeyer HU, Ed. London, Weinheim Academic Press, 1974, p. 1831-1874
28. Grafnetter D: World Health Organization (WHO) coordinated quality control in the lipid laboratory. Giorn Arterioscl 2:113-28, 1977
29. Hatch FT, Lees RS: Practical methods for plasma lipoprotein analysis. In Advances in Lipid Research. Vol 6. Paoletti R, Kritchevsky D, Eds. London, Academic Press, 1968, p. 1-68
30. Lopes-Virella MF, Stone P, Ellis S, Colwell JA: Cholesterol determination in high-density lipoprotein separated by three different methods. Clin Chem 23:882-884, 1977
31. Carlson K: Lipoprotein fractionation. J Clin Pathol 26 (Suppl. 5): 32-37, 1973
32. Folch L, Lees M, Stanley GHS: A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509, 1957
33. Stoffell W, Chu F, Ahrens EH: Analysis of long-chain fatty acids by gas liquid chromatography: micromethod for preparation of methylester. Analyst Chem 31:307-308, 1959
34. Snedecor GW, Cochran WG: Statistical Methods. 7th ed. Ames, IA, Iowa State Univ. Press, 1980, p. 91-116, 172-198
35. Glauber H, Wallace P, Griver K, Brechtel G: Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann int Med 108:663-668, 1988
36. Malasanos TH, Stacpoole PW: Biological effects of ω-3 fatty acids in diabetes mellitus. Diabetes Care 14:1160-1179, 1991
37. Galloway JH, Cartwright IJ, Woodcock BE, Greaves M, Graham R, Russell G, Preston FE: Effects of dietary fish oil supplementation on the fatty acid composition of the human platelet membrane: demonstration of selectivity in the incorporation of eicosapentaenoic acid into membrane phospholipid pools. Clin Sci 68:449-454, 1985
38. Von Schacky C, Siess W, Fischer S, Weber PC: A comparative study of eicosapentaenoic acid metabolism by human platelets in vivo and in vitro. J Lipid Res 26:457-464, 1985
39. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV: The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 328:238-244, 1993
40. Roach PD, Kambouris AM, Trimble RP, Taffing DL, Nestel PJ: The effects of dietary fish oil on hepatic high density and low density lipoprotein receptor activities in the rat. FEBS Lett 222:159-162, 1987
41. Ascherio A, Rimm E, Stampfer MJ, Giovannucci EL, Willett WC: Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 332:978-982, 1995
42. Katan M: Fish and hean disease. N Engl J Med 332:1024-1025, 1995
43. Vuorinen-Markkola H, Yki-Jarvinen H, Taskinen MR: Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory nor antilipolytic effect of insulin in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:161-169, 1993
44. Harris WS, Connor WE, Illingworth RD, Rothrock DW, Foster DM: Effects of fish oil on VLDL triglyceride kinetics in humans. J Lipid Res 31:1549-1558, 1990
45. Randle PJ, Garland PB, Hales CN, Newsholm A: The glucose fatty-acid cycle: its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet 1:785-789, 1963
46. Schectman G, Kaul S, Kissebah AH: Effect of fish oil concentrate on lipoprotein composition in NIDDM. Diabetes 37:1567-1573, 1988